$APVO

$1.28 -$0.22 (14.67%) Close

$APVO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.8M shares outstanding

Who owns APVO?

By type of holder

Institutions 2.8% Insiders 5.8% Everyone else 91.4%

Concentration Top 10 holders own 8.5%

Niowave, Inc. 5.5% · Gsa Capital Partners LLP 1.2%

Institutional ownership

2.8%

-0.2 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

−3.3K

by institutions in Q2 2026

New / sold out

1 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Gsa Capital Partners LLP +1.9K
Barclays PLC NEW +31

Biggest sellers in Q2 2026

UBS Group AG −2.7K
Geode Capital Management, LLC −2.5K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Aptevo Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+41038.9%

+41038.85% a year

Each share's claim on the business

−99.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.17M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years1% Under 1 year99%

Quarterly turnover

6.7%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting APVO on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GC Gsa Capital Partners LLP	21.5K	1.20%	+1.9K (+9.7%)	Q1 '26	0.0%
Shares held by quarter Peak holding21.5K (Q2'26) Change over 8 quarters+21.5K Share of the company1.200% Gsa Capital Partners LLP's full portfolio →
GC Geode Capital Management, LLC	10.8K	0.60%	−2.5K (−18.9%)	Q1 '26	0.0%
Shares held by quarter Peak holding43.7K (Q3'24) Change over 8 quarters−32.9K Share of the company0.600% Geode Capital Management, LLC's full portfolio →

Gsa Capital Partners LLP

21.5K

% of company

1.20%

Change vs last qtr

+1.9K (+9.7%)

Held since

Q1 '26

Geode Capital Management, LLC

10.8K

% of company

0.60%

Change vs last qtr

−2.5K (−18.9%)

Held since

Q1 '26

8 more super investors behind a free account

See every manager holding Aptevo Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting APVO on Form N-PORT; together they hold 1.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$56.4K	12.7K	0.71%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$15.5K	6.4K	0.35%	0.00%	August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$56.4K

% of company

0.71%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$15.5K

% of company

0.35%

% of the fund

0.00%

As of

August 31, 2026

1 more funds behind a free account

See every fund holding Aptevo Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
N Niowave, Inc. Insider	98.5K	5.47%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company5.470% Niowave, Inc.'s insider activity →
WM White Marvin L Insider	1.3K	0.07%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.070% White Marvin L's insider activity →

Niowave, Inc.

Insider

98.5K

% of company

5.47%

Change vs last qtr

—

Held since

—

White Marvin L

Insider

1.3K

% of company

0.07%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Aptevo Therapeutics Inc.

Comments